000 02361 a2200697 4500
005 20250516092806.0
264 0 _c20130114
008 201301s 0 0 eng d
022 _a1468-3288
024 7 _a10.1136/gutjnl-2011-301668
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHueber, Wolfgang
245 0 0 _aSecukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial.
_h[electronic resource]
260 _bGut
_cDec 2012
300 _a1693-700 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAnti-Inflammatory Agents
_xtherapeutic use
650 0 4 _aAntibodies, Monoclonal
_xtherapeutic use
650 0 4 _aAntibodies, Monoclonal, Humanized
650 0 4 _aBayes Theorem
650 0 4 _aBiomarkers
_xmetabolism
650 0 4 _aCrohn Disease
_xdrug therapy
650 0 4 _aDouble-Blind Method
650 0 4 _aDrug Administration Schedule
650 0 4 _aFemale
650 0 4 _aGenetic Markers
650 0 4 _aHumans
650 0 4 _aInfusions, Intravenous
650 0 4 _aInterleukin-17
_xantagonists & inhibitors
650 0 4 _aLeukocyte L1 Antigen Complex
_xmetabolism
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPolymorphism, Single Nucleotide
650 0 4 _aSeverity of Illness Index
650 0 4 _aTreatment Failure
650 0 4 _aYoung Adult
700 1 _aSands, Bruce E
700 1 _aLewitzky, Steve
700 1 _aVandemeulebroecke, Marc
700 1 _aReinisch, Walter
700 1 _aHiggins, Peter D R
700 1 _aWehkamp, Jan
700 1 _aFeagan, Brian G
700 1 _aYao, Michael D
700 1 _aKarczewski, Marek
700 1 _aKarczewski, Jacek
700 1 _aPezous, Nicole
700 1 _aBek, Stephan
700 1 _aBruin, Gerard
700 1 _aMellgard, Bjoern
700 1 _aBerger, Claudia
700 1 _aLondei, Marco
700 1 _aBertolino, Arthur P
700 1 _aTougas, Gervais
700 1 _aTravis, Simon P L
773 0 _tGut
_gvol. 61
_gno. 12
_gp. 1693-700
856 4 0 _uhttps://doi.org/10.1136/gutjnl-2011-301668
_zAvailable from publisher's website
999 _c21789888
_d21789888